Plain-English translation of NCT03731442 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether combining chemotherapy ( and ) with radiation therapy can help esophageal cancer patients whose cancer has returned after surgery. Currently, doctors don't have strong evidence for the best way to treat cancer that comes back. This study aims to show whether this combination treatment—given at the same time—is safer and more effective than other options.
After surgery for esophageal squamous cell carcinoma, cancer comes back in nearly half of patients, often within about 10 months. Previous research from this hospital's patients suggests that combining the two treatments works better than either one alone, but this needs to be proven in a larger, carefully designed study.
You likely qualify if…
You likely don't qualify if…
You will receive chemotherapy ( and ) given every 3 weeks at the same time as radiation therapy targeted to your cancer. Depending on your tumor size and location, you may receive radiation to a smaller area (just where cancer is visible) or a larger area that includes high-risk spots where cancer often returns. Treatment will last several weeks, with imaging scans during and after to monitor how you're responding. A support medication may be given after chemotherapy to help protect your blood cells.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
China